Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why

Benzinga_recent_news03-06 15:15

Calidi Biotherapeutics Inc. (NYSE:CLDI) shares tumbled 35.04% in after-hours trading on Thursday to $0.50. The after-hours rally came after the San Diego-based biotech announced an underwritten public...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2617883716?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/06/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-03-06 15:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617883716","market":"sh","top_or_hot":-1,"title":"Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why","media":"Benzinga_recent_news","content":"<div>\n<p>Calidi Biotherapeutics Inc. (NYSE:CLDI) shares tumbled 35.04% in after-hours trading on Thursday to $0.50.\nThe after-hours rally came after the San Diego-based biotech announced an underwritten public...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/03/51089549/calidi-biotherapeutics-cldi-stock-plunges-35-after-hours-heres-why\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCalidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-06 15:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/03/51089549/calidi-biotherapeutics-cldi-stock-plunges-35-after-hours-heres-why><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Calidi Biotherapeutics Inc. (NYSE:CLDI) shares tumbled 35.04% in after-hours trading on Thursday to $0.50.\nThe after-hours rally came after the San Diego-based biotech announced an underwritten public...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/03/51089549/calidi-biotherapeutics-cldi-stock-plunges-35-after-hours-heres-why\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RSI","symbol_name":"Rush Street Interactive, Inc.","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/03/51089549/calidi-biotherapeutics-cldi-stock-plunges-35-after-hours-heres-why","article_id":"2617883716","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/06/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/03/51089549/calidi-biotherapeutics-cldi-stock-plunges-35-after-hours-heres-why","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2617883716","pubTimestamp":1772781300,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Calidi Biotherapeutics shares plunged after hours following a public offering announcement, trading near their 52-week low.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RSI":"Rush Street Interactive, Inc.","BK4139":"生物科技","CLDI":"CALIDI BIOTHERAPEUTICS INC","BK4150":"赌场与赌博"},"translate_title":"Calidi Biotherapeutics(CLDI)股价盘后暴跌35%-原因如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLDI":1.5,"RSI":1},"content_text":"Calidi Biotherapeutics Inc. (NYSE:CLDI) shares tumbled 35.04% in after-hours trading on Thursday to $0.50.\nThe after-hours rally came after the San Diego-based biotech announced an underwritten public offering after the markets closed on Thursday.\nCalidi plans to offer units of common stock or pre-funded warrants, with the pre-funded warrants available to select investors instead of shares, and each unit will include common warrants.\nCalidi noted it expects to grant underwriters a 45-day overallotment option to purchase up to 15% additional shares.\nAccording to the company’s press release, Ladenburg Thalmann & Co. is the sole book-running manager.\nThe clinical-stage company said it intends to use the proceeds for working capital and general corporate purposes.\nCLDI has a Relative Strength Index (RSI) of 38.68.\nWith a market capitalization of $5.55 million, Calidi has a 52-week range of $0.72 to $19.20.\nThe stock has fallen 92.45% over the past 12 months.\nPrice Action: Calidi Biotherapeutics closed the regular session down 3.12% at $0.77, according to Benzinga Pro data.\nCurrently, the stock is positioned extremely close to its 52-week low.\nBenzinga's Edge Stock Rankings indicate that CLDI has a negative price trend across all time frames.\nPhoto Courtesy: FabrikaSimf on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2617883716","isCrawlerRequest":true}